Cardiovascular disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged >= 18 years, regardless of gender, who received antithrombotic therapy (including antiplatelet or anticoagulant therapy) within 30 days before enrollment and required hospitalization due to gastrointestinal bleeding events; 2. There is obvious bleeding in the gastrointestinal tract and bleeding in the gastroduodenum and small intestine confirmed by gastroscope or enteroscopy; 3. Non-overt gastrointestinal bleeding accompanied by a decrease in hemoglobin of more than 2 g/L; 4. Accompanied by typical gastroduodenal ulcer symptoms for more than 3 days and confirmed by gastroscopy to have multiple erosive lesions accompanied by peptic ulcer symptoms for more than 3 days, or evidence of gastric perforation and obstruction.
Exclusion criteria
Exclusion criteria: 1. In addition to digestive bleeding caused by peptic ulcers, such as varicose vein bleeding caused by portal hypertension, small intestinal malformations, Crohn's disease, ulcerative colitis, Meckel's diverticulum, etc.; 2. Blood system diseases (abnormal blood clotting function); 3. Gastrointestinal tumors; 4. Pregnancy; 5. Refusal to sign informed consent or withdraw from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rebleeding events within 90 days;Rebleeding events;Major Cardiovascular and Cerebrovascular Adverse Events within 90 days;Major Cardiovascular and Cerebrovascular Adverse Events;Antithrombotic strategy;Acid suppression strategy; | — |
Countries
China
Contacts
Beijing Friendship Hospital, Capital Medical University